Allogene Therapeutics Inc. (ALLO) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Allogene Therapeutics Inc...

    NASDAQ: ALLO · Real-Time Price · USD
    1.15
    0.04 (3.60%)
    At close: Sep 05, 2025, 3:59 PM
    1.16
    0.85%
    After-hours: Sep 05, 2025, 07:04 PM EDT

    Allogene Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -257.59M -327.26M -332.63M -257M
    Depreciation & Amortization
    		 13.64M 14.2M 14.29M 10.45M
    Stock-Based Compensation
    		 51.74M 65.95M 83.6M 80.82M
    Other Working Capital
    		 -24.3M -7.8M -1.16M -31.32M
    Other Non-Cash Items
    		 16.26M 24.69M 2.43M 2.61M
    Deferred Income Tax
    		 443K n/a 8.08M 10.4M
    Change in Working Capital
    		 -24.8M -15.3M 3.71M -32.09M
    Operating Cash Flow
    		 -200.3M -237.73M -220.52M -184.81M
    Capital Expenditures
    		 -694K -1.52M -5.19M -21.45M
    Cash Acquisitions
    		 n/a n/a -111.35M -17.71M
    Purchase of Investments
    		 -361.48M -438.63M -248.11M -525.58M
    Sales Maturities Of Investments
    		 437.86M 603.43M 359.46M 728.39M
    Other Investing Acitivies
    		 n/a n/a 111.35M n/a
    Investing Cash Flow
    		 75.69M 163.29M 106.16M 163.66M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 2.28M 4.58M n/a n/a
    Financial Cash Flow
    		 116.67M 95.69M 2.95M 11.96M
    Net Cash Flow
    		 -7.94M 21.25M -111.41M -9.19M
    Free Cash Flow
    		 -200.99M -239.25M -225.71M -206.26M

    Add to Watchlist